This course examines approved and investigational pharmacologic therapies for presbyopia, with focus on efficacy, safety, patient selection, and integration into clinical practice.
Over 1100 attended our event and we received good feedback!
Feedback from anonymous survey:
I enjoyed the informative lecture.
Thank you for info.
Amazing presentation!
Very interesting topic.
Wonderful CE.
Speaker: Dr. Shane Kannarr
Moderator: Dr. Ariel Cerenzie
COPE ID: 100501-PH
Category: Pharmacology
Thank you to Lenz Therapeutics for exhibiting at this event.
This event is COPE approved for 1 hour of CE credit.